276 related articles for article (PubMed ID: 25012996)
1. Incidence of colorectal adenomas: birth cohort analysis among 4.3 million participants of screening colonoscopy.
Brenner H; Altenhofen L; Stock C; Hoffmeister M
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1920-7. PubMed ID: 25012996
[TBL] [Abstract][Full Text] [Related]
2. Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy.
Brenner H; Altenhofen L; Stock C; Hoffmeister M
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1043-51. PubMed ID: 23632815
[TBL] [Abstract][Full Text] [Related]
3. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.
Brenner H; Altenhofen L; Kretschmann J; Rösch T; Pox C; Stock C; Hoffmeister M
Gastroenterology; 2015 Aug; 149(2):356-66.e1. PubMed ID: 25911510
[TBL] [Abstract][Full Text] [Related]
4. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies.
Brenner H; Hoffmeister M; Stegmaier C; Brenner G; Altenhofen L; Haug U
Gut; 2007 Nov; 56(11):1585-9. PubMed ID: 17591622
[TBL] [Abstract][Full Text] [Related]
5. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies.
Brenner H; Hoffmeister M; Brenner G; Altenhofen L; Haug U
Eur J Cancer; 2009 Jul; 45(11):2027-33. PubMed ID: 19289271
[TBL] [Abstract][Full Text] [Related]
6. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M
Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy.
Ferlitsch M; Reinhart K; Pramhas S; Wiener C; Gal O; Bannert C; Hassler M; Kozbial K; Dunkler D; Trauner M; Weiss W
JAMA; 2011 Sep; 306(12):1352-8. PubMed ID: 21954479
[TBL] [Abstract][Full Text] [Related]
8. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
Graser A; Melzer A; Lindner E; Nagel D; Herrmann K; Stieber P; Schirra J; Mansmann U; Reiser MF; Göke B; Kolligs FT
Gastroenterology; 2013 Apr; 144(4):743-750.e2. PubMed ID: 23415805
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a nationwide screening colonoscopy program for colorectal cancer.
Pox CP; Altenhofen L; Brenner H; Theilmeier A; Von Stillfried D; Schmiegel W
Gastroenterology; 2012 Jun; 142(7):1460-7.e2. PubMed ID: 22446606
[TBL] [Abstract][Full Text] [Related]
11. Sex, age, and birth cohort effects in colorectal neoplasms: a cohort analysis.
Brenner H; Altenhofen L; Hoffmeister M
Ann Intern Med; 2010 Jun; 152(11):697-703. PubMed ID: 20513827
[TBL] [Abstract][Full Text] [Related]
12. Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany.
Brenner H; Altenhofen L; Stock C; Hoffmeister M
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):717-23. PubMed ID: 25218160
[TBL] [Abstract][Full Text] [Related]
13. [Age-specific detection rates of colorectal neoplasms by colonoscopic screening in high-incidence rural area].
Li QL; Ma XY; Yu LL; Xue F; Ma WL; Yao KY
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):154-7. PubMed ID: 23714674
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway.
Greuter MJ; Demirel E; Lew JB; Berkhof J; Xu XM; Canfell K; Dekker E; Meijer GA; Coupé VM
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):135-44. PubMed ID: 26598535
[TBL] [Abstract][Full Text] [Related]
15. Which adenomas are detected by fecal occult blood testing? A state-wide analysis from Bavaria, Germany.
Brenner H; Hoffmeister M; Birkner B; Stock C
Int J Cancer; 2015 Apr; 136(7):1672-9. PubMed ID: 25142576
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for advanced colorectal adenomas: a pooled analysis.
Terry MB; Neugut AI; Bostick RM; Sandler RS; Haile RW; Jacobson JS; Fenoglio-Preiser CM; Potter JD
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
[TBL] [Abstract][Full Text] [Related]
17. Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas.
Yang MH; Son HJ; Lee JH; Kim MH; Kim JY; Kim YH; Chang DK; Rhee PL; Kim JJ; Rhee JC
Gastrointest Endosc; 2010 Apr; 71(4):774-81. PubMed ID: 20363417
[TBL] [Abstract][Full Text] [Related]
18. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors.
Cottet V; Pariente A; Nalet B; Lafon J; Milan C; Olschwang S; Bonaiti-Pellié C; Faivre J; Bonithon-Kopp C;
Gastroenterology; 2007 Oct; 133(4):1086-92. PubMed ID: 17919484
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of colorectal adenomas in asymptomatic Korean men and women.
Yang MH; Rampal S; Sung J; Choi YH; Son HJ; Lee JH; Kim YH; Chang DK; Rhee PL; Rhee JC; Guallar E; Cho J
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):499-507. PubMed ID: 24443404
[TBL] [Abstract][Full Text] [Related]
20. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah.
Tuohy TM; Rowe KG; Mineau GP; Pimentel R; Burt RW; Samadder NJ
Cancer; 2014 Jan; 120(1):35-42. PubMed ID: 24150925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
